Outcomes of Local Excision Compared to Radical Excision of Rectal Gastrointestinal Stromal Tumors: A Propensity-Score Matched Analysis of the NCDB.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
accepted:
22
09
2022
pubmed:
12
10
2022
medline:
15
12
2022
entrez:
11
10
2022
Statut:
ppublish
Résumé
Gastrointestinal stromal tumors (GISTs) account for <1% of gastrointestinal cancers. The present study aimed to assess the outcomes of local and radical excision of non-metastatic rectal GISTs. This study was a retrospective cohort analysis of patients with non-metastatic rectal GISTs in the NCDB. Patients were divided according to the surgical approach into local and radical excision and were compared in regard to the baseline characteristics and outcomes. A propensity-score matched analysis was performed to match the two groups for baseline confounders. The main outcomes were 5-year overall survival (OS), surgical margins, hospital stay, short-term mortality, and readmission. 228 patients (54.8% male) with rectal GISTs were included. Before matching, 127 (55.7%) patients underwent local excision and 101 (44.3%) had radical excision. Patients who underwent local excision had more cT1-T2 and low-grade GISTs whereas patients who had radical excision received more neoadjuvant systemic treatment. After matching for clinical T stage, tumor grade, and neoadjuvant systemic therapy, 52 patients were included in each group. Local excision had a significantly higher rate of positive resection margins (42.2% vs. 19.1%, p = 0.02) and a shorter hospital stay (0 vs. 3 days, p < 0.001) than radical excision. The two groups had similar mean OS (139.8 vs. 133.1 months, p = 0.52). Local excision was associated with a significantly higher incidence of positive resection margins and shorter hospital stay, yet similar overall survival to radical excision.
Sections du résumé
BACKGROUND
Gastrointestinal stromal tumors (GISTs) account for <1% of gastrointestinal cancers. The present study aimed to assess the outcomes of local and radical excision of non-metastatic rectal GISTs.
METHODS
This study was a retrospective cohort analysis of patients with non-metastatic rectal GISTs in the NCDB. Patients were divided according to the surgical approach into local and radical excision and were compared in regard to the baseline characteristics and outcomes. A propensity-score matched analysis was performed to match the two groups for baseline confounders. The main outcomes were 5-year overall survival (OS), surgical margins, hospital stay, short-term mortality, and readmission.
RESULTS
228 patients (54.8% male) with rectal GISTs were included. Before matching, 127 (55.7%) patients underwent local excision and 101 (44.3%) had radical excision. Patients who underwent local excision had more cT1-T2 and low-grade GISTs whereas patients who had radical excision received more neoadjuvant systemic treatment. After matching for clinical T stage, tumor grade, and neoadjuvant systemic therapy, 52 patients were included in each group. Local excision had a significantly higher rate of positive resection margins (42.2% vs. 19.1%, p = 0.02) and a shorter hospital stay (0 vs. 3 days, p < 0.001) than radical excision. The two groups had similar mean OS (139.8 vs. 133.1 months, p = 0.52).
CONCLUSIONS
Local excision was associated with a significantly higher incidence of positive resection margins and shorter hospital stay, yet similar overall survival to radical excision.
Identifiants
pubmed: 36221005
doi: 10.1007/s00268-022-06778-5
pii: 10.1007/s00268-022-06778-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
269-277Informations de copyright
© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.
Références
PDQ Adult Treatment Editorial Board (2020) Gastrointestinal stromal tumors treatment (Adult) (PDQ®): Health Professional Version.
Miettinen M, Lasota J (2001) Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1–12
doi: 10.1007/s004280000338
Miettinen M, El-Rifai W, Sobin HL, Lasota J (2002) Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 33:478–83
doi: 10.1053/hupa.2002.124123
Kameyama H, Kanda T, Tajima Y et al (2018) Management of rectal gastrointestinal stromal tumor. Transl Gastroenterol Hepatol 3:8
doi: 10.21037/tgh.2018.01.08
Zhou Z, Chen Z, Chen M et al (2014) Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon. Tumour Biol 35:4357–4362
doi: 10.1007/s13277-013-1572-7
Farid M, Lee MJ, Chew MH et al (2013) Localized gastrointestinal stromal tumor of the rectum: an uncommon primary site with prominent disease and treatment-related morbidities. Mol Clin Oncol 1:190–194
doi: 10.3892/mco.2012.25
Eisenberg BL, Judson I (2004) Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 11:465–475
doi: 10.1245/ASO.2004.09.011
Rutkowski P, Skoczylas J, Wisniewski P (2018) Is the surgical margin in gastrointestinal stromal tumors different? Visc Med 34:347–352
doi: 10.1159/000491649
Centonze D, Pulvirenti E, Pulvirenti D’Urso A et al (2013) Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors. Tech Coloproctol 17:571–574
doi: 10.1007/s10151-013-0976-0
Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480
doi: 10.1056/NEJMoa020461
Nishida T, Shirao K, Sawaki A et al (2008) Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202). Int J Clin Oncol 13:244–251
doi: 10.1007/s10147-007-0746-y
Wei J, Zhong J, Chen Z et al (2022) Survival outcome of local vs radical excision in rectal gastrointestinal stromal tumor: a SEER database analysis. BMC Surg 22:215
doi: 10.1186/s12893-022-01485-3
Hou YY, Lu SH, Zhou Y et al (2009) Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors. Mod Pathol 22:556–569. https://doi.org/10.1038/modpathol.2009.11
doi: 10.1038/modpathol.2009.11
Jakob J, Hohenberger P (2018) Neoadjuvant therapy to downstage the extent of resection of gastrointestinal stromal tumors. Visc Med 34(5):359–365. https://doi.org/10.1159/000493405
doi: 10.1159/000493405
Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates Publishers, Hillsdale
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458
doi: 10.1038/bmt.2012.244
Baik SH, Kim NK, Lee CH et al (2007) Gastrointestinal stromal tumor of the rectum: an analysis of seven cases. Surg Today 37:455–459
doi: 10.1007/s00595-006-3424-1
Choti MA (2022) Gastrointestinal stromal tumors (GISTs). Medscape. Available online at https://emedicine.medscape.com/article/278845-overview#a5 .
Jakob J, Mussi C, Ronellenfitsch U et al (2013) Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Ann Surg Oncol 20:586–592
doi: 10.1245/s10434-012-2647-1
Wang T, Zhao Y, Wang M et al (2021) Radical resection versus local excision for low rectal gastrointestinal stromal tumor: a multicenter propensity score-matched analysis. Eur J Surg Oncol 47:1668–1674
doi: 10.1016/j.ejso.2021.01.027
Guo W, Yang Z, Wei Y et al (2020) Radical excision versus local resection for primary rectal gastrointestinal stromal tumors. Cohort Study Int J Surg 77:190–197
doi: 10.1016/j.ijsu.2020.03.068
IJzerman NS, Mohammadi M, Tzanis D et al (2020) Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort. Eur J Surg Oncol 46:1124–1130
doi: 10.1016/j.ejso.2020.02.033
Rutkowski P, Skoczylas J, Wisniewski P (2018) Is the surgical margin in gastrointestinal stromal tumors different? Visc Med 34(5):347–352. https://doi.org/10.1159/000491649
doi: 10.1159/000491649
Shu P, Sun XF, Fang Y et al (2020) Clinical outcomes of different therapeutic modalities for rectal gastrointestinal stromal tumor: summary of 14-year clinical experience in a single center. Int J Surg 77:1–7
doi: 10.1016/j.ijsu.2020.03.007
McCarter MD, Antonescu CR, Ballman KV et al (2012) Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. J Am Coll Surg 215:53–59
doi: 10.1016/j.jamcollsurg.2012.05.008
Gouveia AM, Pimenta AP, Capelinha AF, de la Cruz D, Silva P, Lopes JM (2008) Surgical margin status and prognosis of gastrointestinal stromal tumor. World J Surg 32:2375–2382
doi: 10.1007/s00268-008-9704-8
Singer S, Rubin BP, Lux ML et al (2002) Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20:3898–3905
doi: 10.1200/JCO.2002.03.095
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58
doi: 10.1097/00000658-200001000-00008
Laurent M, Brahmi M, Dufresne A et al (2019) Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectives. Transl Gastroenterol Hepatol 4:24
doi: 10.21037/tgh.2019.03.07
Kumar A, Guss ZD, Courtney PT et al (2020) Evaluation of the use of cancer registry data for comparative effectiveness research. JAMA Netw Open 3(7):e2011985. https://doi.org/10.1001/jamanetworkopen.2020.11985
doi: 10.1001/jamanetworkopen.2020.11985
Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399–424. https://doi.org/10.1080/00273171.2011.568786
doi: 10.1080/00273171.2011.568786